Drug intelligence / Profile preview

Tianhu Capsule

Development stage
Unknown
Lead developer
Sichuan Lele Pharmaceutical Technology Development
Modality
Small Molecules
Administration
Oral
01

Overview

Tianhu Capsule is a Traditional Chinese Medicine (TCM) formulation developed by Sichuan Lele Pharmaceutical Technology Development Co., Ltd. for the treatment of benign prostatic hyperplasia (BPH) and chronic prostatitis. The medication is composed of several herbal ingredients, including *Polygonum cuspidatum* (Huzhang) and *Semiaquilegia adoxoides* (Tiankuizi), which are traditionally used to clear heat, resolve dampness, and dissipate nodules. Pharmacological studies indicate that Tianhu Capsule works by inhibiting the expression of growth factors such as transforming growth factor-beta 1 (TGF-β1) and basic fibroblast growth factor (bFGF) in prostate tissue, which are key drivers of stromal and epithelial cell proliferation. By modulating these pathways, the drug helps reduce prostate volume and alleviate lower urinary tract symptoms (LUTS) such as urinary frequency, urgency, and weak stream. It is approved in China as a Chinese Patent Medicine.

Brand names
Tianhu Capsule
Other names
Tianhu Jiaonang
02

Targets

FGF2TGFB1 (Transforming growth factor Beta-1 proprotein)

Beyond the preview

Go deeper on Tianhu Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tianhu Capsule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call